Showing results (661-670 of 1,190) with videos related to

Sort By:
Pageof 119
BMC Pharmacology & Toxicology|December 4, 2019
Complete atrioventricular block due to timolol eye drops: a case report and literature reviewZhuoying Wang, Ian Denys, Feng Chen, et al.
BMC Pharmacology & Toxicology|January 7, 2019
First-in-human study assessing safety, tolerability, and pharmacokinetics of 2-hydroxybenzylamine acetate, a selective dicarbonyl electrophile scavenger, in healthy volunteersLisa M Pitchford, John A Rathmacher, John C Fuller, et al.
BMC Pharmacology & Toxicology|December 5, 2020
Efficacy and safety of bempedoic acid alone or combining with other lipid-lowering therapies in hypercholesterolemic patients: a meta-analysis of randomized controlled trialsXiang Zhao, Xubiao Ma, Xing Luo, et al.
BMC Pharmacology & Toxicology|October 29, 2020
Oritavancin for the treatment of complicated gram-positive infection in persons who inject drugsAileen Ahiskali, Heather Rhodes
BMC Pharmacology & Toxicology|November 29, 2018
Outcomes following calcium channel blocker exposures reported to a poison information centerMikkel B Christensen, Kasper M Petersen, Søren Bøgevig, et al.
BMC Pharmacology & Toxicology|January 6, 2022
The teratogenic effect of pregabalin on heart, liver and kidney in rats: a light microscopic, electron microscopic and immunohistochemical studyOmnia I Ismail, Eman S Shaltout, Nora Z Abdellah, et al.
BMC Pharmacology & Toxicology|September 5, 2022
Effects of rosuvastatin on serum glucose and insulin in hyperuricemic ratsDilidaer Xilifu, Zumulaiti Tuerxun, Buweiayixiemu Nuermaimaiti, et al.
BMC Pharmacology & Toxicology|September 6, 2022
Prediction of mortality and morbidity following paraquat poisoning based on trend of liver and kidney injuryFarzad Gheshlaghi, Jamileh Haghirzavareh, Anselm Wong, et al.
BMC Pharmacology & Toxicology|January 11, 2022
Open-access database of literature derived drug-related Torsade de Pointes casesLaura Krumpholz, Barbara Wiśniowska, Sebastian Polak
BMC Pharmacology & Toxicology|January 18, 2022
Comparative risk of incidence and clinical outcomes of COVID-19 among proton pump inhibitor and histamine-2 receptor antagonist short-term users: a nationwide retrospective cohort studyJimyung Park, Seng Chan You, Jaehyeong Cho, et al.
Pageof 119